Subject(s)
Interferon-gamma/metabolism , Leukocytes, Mononuclear/immunology , Tuberculosis, Ocular/diagnosis , Tuberculosis, Ocular/immunology , Uveitis/diagnosis , Uveitis/immunology , Humans , Immunologic Tests , Interferon-gamma/analysis , Leukocytes, Mononuclear/metabolism , Mycobacterium tuberculosis/immunology , Tuberculosis, Ocular/microbiology , Uveitis/microbiologyABSTRACT
The objective of this study was to investigate whether the restored immune functions of vertically human immunodeficiency virus (HIV)-infected children who were severely immunodeficient before the initiation of highly active anti-retroviral therapy (HAART) are comparable to those of untreated slow progressors. We therefore assessed T cell proliferation and cytokine [interferon (IFN)-γ, interleukin (IL)-5 and IL-13] secretions after mitogen, recall antigens and HIV-1-specific stimulation in 12 untreated slow progressors, 16 untreated progressors and 18 treated patients. Treated children were profoundly immunodeficient before the initiation of HAART and had long-lasting suppression of viral replication on treatment. We demonstrated that slow progressors are characterized not only by the preservation of HIV-1-specific lymphoproliferative responses but also by the fact that these responses are clearly T helper type 1 (Th1)-polarized. Children on HAART had proliferative responses to HIV-1 p24 antigen, purified protein derivative (PPD) and tetanus antigen similar to slow progressors and higher than those of progressors. However, in contrast to slow progressors, most treated children exhibited a release of Th2 cytokines accompanying the IFN-γ secretion in response to the HIV-1 p24 antigen. Moreover, despite higher proliferative responses to phytohaemagglutinin (PHA) than the two groups of untreated children, treated children had lower levels of IFN-γ secretion in response to PHA than slow progressors. These data show that in severely immunodeficient vertically HIV-infected children, a long-lasting HAART allows recovering lymphoproliferative responses similar to untreated slow progressors. However, alterations in IFN-γ secretion in response to the mitogen PHA persisted, and their cytokine release after HIV-specific stimulation was biased towards a Th2 response.
Subject(s)
HIV Infections/drug therapy , HIV Infections/transmission , HIV-1/physiology , Infectious Disease Transmission, Vertical , T-Lymphocytes/drug effects , Adolescent , Antiretroviral Therapy, Highly Active , Cell Proliferation , Cells, Cultured , Child , Child, Preschool , Cytokines , Disease-Free Survival , Female , HIV Core Protein p24/immunology , HIV Infections/immunology , HIV-1/pathogenicity , Humans , Infant , Lymphocyte Activation , Male , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Th1-Th2 Balance , Young AdultABSTRACT
Detailed phenotypic characterization of B cell subpopulations is of utmost importance for the diagnosis and management of humoral immunodeficiencies, as they are used for classification of common variable immunodeficiencies. Since age-specific reference values remain scarce in the literature, we analysed by flow cytometry the proportions and absolute values of total, memory, switched memory and CD21(-/low) B cells in blood samples from 168 healthy children (1 day to 18 years) with special attention to the different subpopulations of CD21(low) B cells. The percentages of total memory B cells and their subsets significantly increased up to 5-10 years. In contrast, the percentages of immature CD21(-) B cells and of immature transitional CD21(low)CD38(hi) B cells decreased progressively with age, whereas the percentage of CD21(low) CD38(low) B cells remained stable during childhood. Our data stress the importance of age-specific reference values for the correct interpretation of B cell subsets in children as a diagnostic tool in immunodeficiencies.
Subject(s)
B-Lymphocyte Subsets/immunology , Common Variable Immunodeficiency/classification , ADP-ribosyl Cyclase 1/immunology , Adolescent , Antigens, CD19/immunology , Child , Child, Preschool , Cohort Studies , Common Variable Immunodeficiency/diagnosis , Common Variable Immunodeficiency/immunology , Flow Cytometry , Humans , Immunophenotyping , Infant , Infant, Newborn , Lymphocyte Count , Receptors, Complement 3d/immunology , Reference Values , Tumor Necrosis Factor Receptor Superfamily, Member 7/immunologyABSTRACT
BACKGROUND: Positive skin prick tests (SPT) for food allergens and specific IgE (sIgE) in serum indicate sensitization but do not enable distinction between sensitized but tolerant and clinically allergic patients. OBJECTIVE: Herein, we evaluate the clinical relevance of basophil activation tests (BATs) for peanut or egg allergy diagnosis. METHODS: Thirty-two peanut-allergic, 14 peanut-sensitized (sIgE(+) and/or SPT(+) to peanuts) but tolerant children and 29 controls with no history of an adverse reaction to peanuts were included. Similarly, 31 egg-allergic, 14 egg-sensitized children (sIgE(+) and/or SPT(+) to egg white) and 22 controls were studied. Flow cytometric analysis of CD63 expression or CD203c upregulation on basophils and the production of leukotrienes (LT) were performed in response to an in vitro crude peanut extract or ovalbumin (OVA) challenge. RESULTS: After in vitro peanut challenge, the basophils from peanut-allergic children showed significantly higher levels of activation than those from controls (P<0.001). After OVA challenge, a similar distinction (P<0.001) was observed between egg-allergics and controls. Interestingly, the majority of egg- or peanut-sensitized children failed to activate basophils, respectively, in response to OVA and peanut challenge. The sensitivity of the CD63, CD203c and LT assay was 86.7%, 89.5% and 76.0% with a specificity of 94.1%, 97.1% and 94.6% for peanut allergy diagnosis. The corresponding performances of BATs applied to egg allergy diagnosis were 88.9%, 62.5% and 77.8% for the sensitivity and 100%, 96.4% and 96.4% for the specificity. CONCLUSION: Neither conventional tests nor BATs are sensitive and specific enough to predict food allergy accurately. However, BATs may helpfully complete conventional tests, especially SPT, allowing improved discrimination between allergic and non-allergic individuals.
Subject(s)
Basophil Degranulation Test/methods , Basophils/immunology , Egg Hypersensitivity/diagnosis , Eggs/adverse effects , Peanut Hypersensitivity/diagnosis , Adolescent , Antigens, CD/blood , Child , Child, Preschool , Dose-Response Relationship, Immunologic , Egg Hypersensitivity/blood , Egg Hypersensitivity/immunology , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Immunoglobulin E/blood , Infant , Leukotrienes/immunology , Male , Peanut Hypersensitivity/blood , Peanut Hypersensitivity/immunology , Phosphoric Diester Hydrolases/blood , Platelet Membrane Glycoproteins , Pyrophosphatases/blood , Sensitivity and Specificity , Skin Tests , Tetraspanin 30ABSTRACT
The functional repertoire of T cells in abdominal aortic aneurysm (AAA) and the exact nature of aortic wall adaptive cellular immune responses still remains a matter of debate. In this study, we sought to determine whether type 1 or type 2 responses occur predominantly in human aneurysmal aortic lesions. We first examined the phenotype and cytokine secretion profile of T lymphocytes freshly isolated from aneurysmal aortic wall for comparison with their circulating counterparts using flow cytometry. We found that both populations of infiltrating CD4(+) and CD8(+)T cells displayed a unique activated memory phenotype. In addition, we identified the presence in human aneurysmal aortic lesion of CD4(+)T cells producing high levels of interferon (IFN)-gamma but not interleukin (IL)-4, reflecting their type 1 nature. Quantitative analysis of cytokine gene expression confirmed increased IFN-gamma transcript levels in infiltrating cells compared to controls. We next analysed aortic wall responses using LightCycler-based quantitative real-time reverse transcription-polymerase chain reaction. Compared to control non-diseased aortic samples, we demonstrated that whole AAA tissues exhibited high mRNA levels of IFN-gamma but not IL-4. Overexpression of the transcription factor T-bet in the absence of significant GATA-3 expression further assessed the type 1 polarization of aortic wall immune responses. These findings indicate that type 1 CD4(+)T cells predominate in human AAA lesions. This study has important implications for the pathogenesis of aneurysm disease. Through the production of IFN-gamma, T cells may indeed contribute to orchestrate extracellular matrix remodelling.
Subject(s)
Aortic Aneurysm, Abdominal/immunology , T-Lymphocytes, Helper-Inducer/immunology , Aged , Aged, 80 and over , Antigens, CD/immunology , Aorta, Abdominal/immunology , CD8-Positive T-Lymphocytes/immunology , Cells, Cultured , Female , Gene Expression , Humans , Immunologic Memory/immunology , Interferon-gamma/analysis , Interferon-gamma/immunology , Interleukin-4/immunology , Interleukins/immunology , Male , Middle Aged , Phenotype , T-Box Domain Proteins , Th1 Cells/immunology , Th2 Cells/immunology , Transcription Factors/analysis , Transcription Factors/immunologyABSTRACT
The idiopathic hypereosinophilic syndrome is associated with expansion of an IL-5-producing T-cell subset in a subgroup of patients. Identification of such patients is critical to adequate management because there is some evidence that they present an increased risk for development of T-cell lymphoma. Although the T(H)2-like cells often bear an aberrant surface phenotype and can readily be detected with flow cytometry, we now show that lymphocyte phenotyping might be normal in some cases. In contrast, serum thymus and activation-regulated chemokine levels are consistently increased in such patients compared with others with persistent idiopathic hyper-eosinophilia and could therefore represent a useful diagnostic tool.
Subject(s)
Chemokines, CC/blood , Hypereosinophilic Syndrome/blood , Hypereosinophilic Syndrome/diagnosis , Lymphocytosis/blood , Lymphocytosis/diagnosis , Adolescent , Adult , Chemokine CCL17 , Female , Humans , Interleukin-5/blood , Male , Middle Aged , T-Lymphocytes/cytologyABSTRACT
New immunotherapies derived from biotechnology offer fascinating perspectives in different fields of medicine including anti-infectious vaccines, cancer, organ transplantation and autoimmune diseases. In this paper, we illustrate how the Department of Immunology can contribute to the development of these new treatments within a academic hospital such as the Erasme Hospital at the Université Libre de Bruxelles.
Subject(s)
Allergy and Immunology , Blood Transfusion , Hematology , Hospital Departments , Belgium , Biomedical Research , Hospitals, University , HumansABSTRACT
We analyzed the expression of chemokine receptors on clonal Th2-type CD4(+)CD3(- )lymphocytes isolated from blood of two patients with chronic hypereosinophilia. First, we observed that these Th2 cells express membrane CCR5 and CXCR4 but neither CCR3 nor CCR4 when analyzed immediately after purification. However, CCR4 appeared following culture in human serum-free medium, suggesting that it was down-regulated in vivo. Indeed, patient's serum, but not control human serum, strongly down-regulated CCR4 expression on cultured Th2 cells. As high levels of TARC, a CCR4 ligand, were detected in the serum of four hypereosinophilic patients with CD3(-)CD4(+) clonal Th2 cells, we evaluated the effect of TARC neutralization in this system. Addition of a neutralizing anti-TARC mAb inhibited CCR4 down-regulation by patient's serum, indicating that circulating TARC contributed to CCR4 down-regulation on Th2 cells in vivo. Clonal Th2 cells did not secrete high levels of TARC themselves but induced a sustained production of TARC by monocyte-derived dendritic cells, a phenomenon that was inhibited by addition of blocking mAb against IL-4 receptor. We conclude that high circulating levels of TARC in serum of patients with chronic hypereosinophilia, most likely derived from antigen-presenting cells stimulated by Th2-type cytokines, induce down-regulation of CCR4 on Th2 cells in vivo.
Subject(s)
Chemokines, CC/metabolism , Down-Regulation , Hypereosinophilic Syndrome/pathology , Receptors, Chemokine/metabolism , Th2 Cells/metabolism , Th2 Cells/pathology , Adult , Calcium/metabolism , Calcium Signaling/drug effects , Cells, Cultured , Chemokine CCL11 , Chemokine CCL17 , Chemokine CCL22 , Chemokine CCL5/pharmacology , Chemokine CXCL12 , Chemokines, CC/biosynthesis , Chemokines, CC/blood , Chemokines, CC/pharmacology , Chemotaxis, Leukocyte/drug effects , Chronic Disease , Clone Cells/drug effects , Clone Cells/metabolism , Clone Cells/pathology , Coculture Techniques , Cytokines/pharmacology , Dendritic Cells/cytology , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Down-Regulation/drug effects , Female , Flow Cytometry , Humans , Hypereosinophilic Syndrome/metabolism , Interleukin-13/pharmacology , Interleukin-4/pharmacology , Middle Aged , Receptors, CCR4 , Th2 Cells/drug effectsABSTRACT
A recent study identified a clonal expansion of CD3(-)CD4(+)cells secreting Th2-type cytokines in 4 patients with chronic hypereosinophilia. Because interferon alpha (IFN-alpha) is used in the therapy of the idiopathic hypereosinophilic syndrome, the effects of this cytokine on the survival of clonal Th2 cells isolated from the blood of 2 patients were determined. First, these cells displayed a high rate of spontaneous apoptosis on culture in cytokine-free medium and were also sensitive to Fas-mediated apoptosis induced by soluble Fas ligand. Addition of IFN-alpha or interleukin-2 (IL-2) to culture medium resulted in significant protection against spontaneous but not Fas-induced apoptosis. Although spontaneous apoptosis of the clonal Th2 cells was clearly associated with down-regulation of both bcl-2 and bcl-x(L) levels, IFN-alpha had no significant effect on the expression of these antiapoptotic proteins, whereas addition of IL-2 resulted in higher levels of bcl-2. On the other hand, IFN-alpha decreased the numbers of cells with disrupted mitochondrial transmembrane potential both during spontaneous apoptosis and after exposure to protoporphyrin IX. Thus, IFN-alpha might promote the survival of clonal Th2 cells, an effect that could be relevant to the therapeutic approach for patients with chronic hypereosinophilia caused by clonal expansion of Th2-type cells. (Blood. 2000;96:4285-4292)
Subject(s)
Apoptosis/drug effects , Hypereosinophilic Syndrome/immunology , Interferon-alpha/pharmacology , Th2 Cells/drug effects , Adult , Cells, Cultured , Chronic Disease , Clone Cells/drug effects , Fas Ligand Protein , Female , Gene Expression Regulation , Genes, bcl-2 , Humans , Hypereosinophilic Syndrome/drug therapy , Hypereosinophilic Syndrome/pathology , Immunologic Memory , Immunophenotyping , Interferon alpha-2 , Interferon-alpha/therapeutic use , Interleukin-2/pharmacology , Intracellular Membranes/drug effects , Membrane Glycoproteins/pharmacology , Mitochondria/drug effects , Permeability/drug effects , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Protoporphyrins/pharmacology , Reactive Oxygen Species , Recombinant Proteins/pharmacology , Superoxides/metabolism , bcl-X Protein , fas Receptor/physiologyABSTRACT
BACKGROUND: Kaposi's sarcoma (KS) is commonly thought to be derived from endothelial cells because of the predominant expression of endothelial markers in KS lesions. However, the heterogeneity of the spindle-cell compartment makes the precise lineage relationship of KS tumour cells unclear. Cultured KS-derived spindle cells constitutively overexpress antiapoptotic proteins and exhibit invasive properties, which suggests that they may adequately represent the tumour cells of KS. OBJECTIVES: We aimed to investigate the expression of a wide variety of immunohistochemical markers by spindle cells derived from patch-, plaque- and nodular-stage lesions from patients with iatrogenic, sporadic and acquired immune deficiency syndrome-related KS, and to review the data reported by other laboratories. METHODS: Cells from six KS cell cultures derived from four subjects were examined by immunostaining. RESULTS: Comparison of these data indicates that KS-derived spindle cells generally express myofibroblast antigens but lack endothelial and/or leucocyte markers. CONCLUSIONS: As the myofibroblast phenotype is not the predominant feature of KS tissues, our findings further substantiate the view that the in vivo dominant endothelial population represents a reactive hyperplasia rather than the true KS tumour process.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Neoplasm Proteins/metabolism , Sarcoma, Kaposi/metabolism , Skin Neoplasms/metabolism , Endothelium/metabolism , Flow Cytometry , Humans , Neoplasm Staging , Phenotype , Sarcoma, Kaposi/etiology , Sarcoma, Kaposi/pathology , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Tumor Cells, CulturedABSTRACT
The subcomponents of bacille Calmette-Guérin (BCG) involved in the mechanism of action of intravesical BCG immunotherapy used for prophylaxis of superficial bladder cancer recurrences have been poorly investigated. We purified various BCG subcomponents and analyzed in vitro their ability to enhance a Th1 polarized immune response as well as to increase lymphocyte-mediated cytotoxicity against bladder tumors. Human peripheral blood mononuclear cells (PBMCs) from healthy purified protein derivative-positive subjects were incubated for 7 days with whole BCG and various fractions (BCG cell wall, plasma membrane, cytosol, purified polysaccharides as glucan or arabinomannan, purified native proteins from BCG culture filtrate, recombinant 22 kDa protein, phosphate transporter PstS-2 and -3 proteins). IFN-gamma, IL-12, IL-2, and IL-6 production by stimulated PBMCs was compared to unstimulated controls and the phenotype of expanded cells analyzed by flow cytometry (FACS analysis). A (51)Cr-release assay monitored the cytotoxicity of amplified effector cells against T24 bladder tumor cells. Live BCG and most of its subcomponents (with the exception of cytosol, PstS-2 and -3) significantly enhanced IFN-gamma and IL-12 secretion, expanded CD3(-)CD56(+) cells and the non-MHC-restricted cytotoxicity against bladder tumor cells compared to unstimulated controls (all P < 0.001, t-test). IL-2 receptor blockage resulted in a clear reduction in the cytotoxic activity of stimulated PBMCs. Numerous BCG subcomponents thus provide positive stimuli for Th1 cell differentiation and enhance in vitro, non-MHC-restricted cytotoxicity against bladder tumor cells. Our findings provide the basis for the therapeutic use of several of these subfractions in experimental animal models bearing bladder tumors.
Subject(s)
Antigens, Bacterial/immunology , BCG Vaccine/immunology , Antigens, Bacterial/analysis , Antigens, CD/biosynthesis , BCG Vaccine/therapeutic use , Bacterial Outer Membrane Proteins/physiology , CD56 Antigen/biosynthesis , Humans , Interferon-gamma/biosynthesis , Interleukin-12/biosynthesis , Interleukin-2/biosynthesis , Interleukin-6/biosynthesis , Leukocytes, Mononuclear/metabolism , Neoplasm Proteins/biosynthesis , Th1 Cells/immunology , Tumor Cells, Cultured , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/therapyABSTRACT
Idiopathic hypereosinophilic syndrome (HES) and Gleich's syndrome are related disorders characterized by persistent or recurrent hypereosinophilia of unknown origin. Elevated IgE levels and polyclonal hypergammaglobulinaemia are considered as markers of benign outcome in this setting as they are generally associated with predominant cutaneous manifestations and favourable response to glucocorticoid therapy. In a previous study, we identified a clonal population of CD3-CD4+ Th2-like lymphocytes secreting interleukin (IL)-5 and IL-4 in peripheral blood of a patient fulfilling the diagnostic criteria of HES with associated serum hyper-IgE. We now extend this observation by describing identical findings in three additional patients, and we compare their clinical and biological parameters with five other patients with HES. Chromosomal abnormalities were detected in purified CD3-CD4+ Th2 cells from three patients, among whom one developed anaplastic null cell lymphoma. We therefore suggest that a careful search for T-lymphocyte clonality and cytogenetic changes should be included in the work-up of HES for adequate management.
Subject(s)
Hypereosinophilic Syndrome/immunology , Th2 Cells/immunology , Adult , Case-Control Studies , Clone Cells , Female , Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor , Humans , Immunoglobulin E/blood , Immunophenotyping , Interleukin-13/analysis , Interleukin-4/analysis , Interleukin-5/analysis , Male , Middle Aged , Polymerase Chain ReactionABSTRACT
Interleukin-5 produced by Th2-type lymphocytes is involved in the pathogenesis of a number of hypereosinophilic disorders. We and others have identified clonal Th2 cells with abnormal surface phenotypes in peripheral blood of certain patients presenting the idiopathic hypereosinophilic syndrome. We took advantage of the CD3- CD4+ phenotype of our patients' T cells to determine the activation signals involved in their production of Th2 cytokines and expansion, independently of T cell receptor engagement. In vitro cocultures performed with dendritic cells demonstrated the critical role of co-stimulatory signalling through B.7/CD28 and LFA-3/CD2 pathways and the involvement of an autocrine IL2/IL2R loop in the activation of these Th2-type cells. The high-level spontaneous apoptosis displayed by these cells in vitro was drastically inhibited by IL2 and IFN-alpha. New therapeutic strategies could result from our observations. Indeed, the hypereosinophilic syndrome may represent an unexpected application of new immunomodulatory molecules such as CTLA4-Ig and anti-IL2R-alpha.
Subject(s)
Hypereosinophilic Syndrome/physiopathology , Interferon-alpha/immunology , Interleukin-2/immunology , T-Lymphocytes/immunology , Apoptosis , Dendritic Cells , Humans , Hypereosinophilic Syndrome/immunology , Interferon-alpha/pharmacology , Interleukin-2/pharmacology , Signal TransductionSubject(s)
Eosinophilia/drug therapy , Hypereosinophilic Syndrome/immunology , Interferon-alpha/therapeutic use , T-Lymphocytes/immunology , Apoptosis/immunology , Eosinophilia/immunology , Humans , Interferon alpha-2 , Interferon-alpha/pharmacology , Lymphoma, T-Cell/chemically induced , Recombinant Proteins , T-Lymphocytes/drug effectsABSTRACT
We studied the effects of interferon-beta (IFN-beta) on the differentiation of dendritic cells (DC) obtained by culturing plastic-adherent peripheral blood mononuclear cells (PBMC) from a total of 30 healthy volunteers in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). First, we found that the addition of IFN-beta at the initiation of the culture did not modify DC morphology but caused a reproducible and statistically significant upregulation of HLA-DR, CD86, and CD80 surface expression. CD1a expression was significantly reduced, and CD40 expression was unchanged. We then determined the influence of IFN-beta on the production of cytokines by DC. DC differentiated in the presence of IFN-beta secreted significantly less IL-12 (p40 and p70) both spontaneously and on activation by fibroblasts transfected with the CD40L gene. This effect of IFN-beta was dose dependent and selective, as it was not observed for IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha). As a consequence, DC differentiated in the presence of IFN-beta induced significantly less IFN-gamma secretion by alloreactive T cells, whereas they were more efficient than control DC in eliciting IL-5 secretion. We conclude that the direct action of IFN-beta on DC causes inhibition of their ability to secrete IL-12 in response to CD40 ligation and to elicit Th1 type responses.
Subject(s)
CD40 Antigens/blood , Dendritic Cells/drug effects , Interferon-beta/pharmacology , Interleukin-12/metabolism , Leukocytes, Mononuclear/drug effects , Cell Differentiation/drug effects , Cells, Cultured , Granulocyte-Macrophage Colony-Stimulating Factor/blood , Humans , Leukocytes, Mononuclear/cytology , Phenotype , Recombinant Proteins/pharmacology , Reference Values , Reproducibility of Results , Secretory Rate/drug effectsABSTRACT
INTRODUCTION: A case of Kimura's disease that occurred in a 5-year-old Caucasian boy after a tick bite is reported. When the child was 16 years old, symptoms developed. They included voluminous bilateral neck and head lymph nodes associated with hypereosinophilia (1,640/mm3), and increased IgE levels (18,866 KU/L). Clinical and immunological effects of treatment by interferon-alpha and steroids are presented. EXEGESIS: Pathological and histological examination showed typical features of dense lymphoid cell infiltrates containing many eosinophils, mast cells, and vascular hyperplasia. Percentages of CD4+, CD27-, CD7- cells were increased In the blood and lymph nodes, showing a profile typical of TH2. IL-5 production by these cells was markedly increased and was inhibited by IFN-alpha and IFN-beta in vitro. No etiology was found. The role of antigens of Ixodes ricinus is discussed. Three surgical excisions of adenopathies were not successful. Treatment by IFN-alpha (Introna, Schering-Plough, 5.10(6) U/week) and a bolus of methylprednisolone hemisuccinate (1 g/month) was started. Eight months later, the size of the lymph nodes had decreased; however, eosinophil counts and ECP and IgE levels were still high. The decrease in corticosteroid induced a subsequent, slight increase in the size of the lymph nodes and a marked increase in ECP. CONCLUSION: This is the first description of treatment of Kimura's disease by interferon-alpha and steroids. The disease outcome does not suggest that interferon-alpha may predominate.
Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/therapy , Anti-Inflammatory Agents/therapeutic use , Interferon-alpha/therapeutic use , Methylprednisolone Hemisuccinate/therapeutic use , Adolescent , Angiolymphoid Hyperplasia with Eosinophilia/diagnosis , Angiolymphoid Hyperplasia with Eosinophilia/immunology , Eosinophilia/diagnosis , Humans , Hypergammaglobulinemia/diagnosis , Immunoglobulin G , Magnetic Resonance Imaging , MaleABSTRACT
We recently observed a clonal expansion of CD3(-)CD4(+) T cells secreting Th2-type cytokines in patients presenting chronic hypereosinophilia. As clonal T cells isolated from such patients did not spontaneously secrete cytokines in vitro, we reasoned that costimulatory signals delivered by antigen-presenting cells might be required to induce their full activation. To address this question, we investigated in two such patients the responses of CD3(-)CD4(+) T cells to dendritic cells (DC). DC elicited proliferation and production of interleukin-5 (IL-5) and IL-13 by clonal cells from patient 1 and upregulated their expression of CD25 (IL-2R-alpha). These effects were abolished when blocking monoclonal antibodies (MoAbs) against IL-2R-alpha and IL-2 were added to cocultures, indicating critical involvement of an autocrine IL-2/IL-2R pathway. Cells from patient 2 were stimulated by DC to produce Th2 cytokines only when rIL-2 or rIL-15 was added to cocultures. In both patients, addition of inhibitory MoAbs against B7-1/B7-2 or CD2 to cocultures resulted in dramatic reduction of cytokine production and inhibited CD25 upregulation. Thus, TCR/CD3-independent activation of clonal Th2 cells by DC is an IL-2-dependent process, which requires signaling through CD2 and CD28.
Subject(s)
Cytokines/immunology , Eosinophilia/immunology , Receptors, Antigen, T-Cell/immunology , Th2 Cells/immunology , Adult , CD3 Complex , CD4 Antigens , Cell Differentiation/immunology , Clone Cells/immunology , Eosinophilia/pathology , Female , Humans , Lymphocyte Activation , Th2 Cells/pathologyABSTRACT
Clinical studies have demonstrated beneficial effects of interferon-beta (IFN-beta) therapy in multiple sclerosis (MS) patients. However, the mechanism of action of IFN-beta in MS remains unknown. IFN-beta has even been demonstrated to enhance isolated T cell secretion of IFN-gamma, a cytokine proven to be deleterious in MS. However, IFN-beta inhibits IFN-gamma secretion of T cells, when they are stimulated by antigen presenting cells (APC). We therefore decided to study the effects of IFN-beta on the in vitro differentiation of dendritic cells (DC), a major class of APC. First, we found that the addition of IFN-beta at the initiation of the differentiation did not modify DC morphology, but enhanced the expression of molecules involved in antigen presentation (HLA-DR, B7/1 and B7/2). However, DC, differentiated in the presence of IFN-beta, secreted less interleukin-12 (IL-12) both spontaneously and upon activation by CD40-ligand bearing cells. As a consequence, DC differentiated in the presence of IFN-beta induced less IFN-gamma secretion by alloreactive T cells. We conclude that the direct action of IFN-beta on DC results in inhibition of their ability to secrete IL-12 and to elicit Thelper-1 (Th-1) type responses. These results are of particular interest in MS, in which a critical role for IL-12 has recently been suggested by a number of clinical and experimental observations.
Subject(s)
Dendritic Cells/drug effects , Interferon-beta/therapeutic use , Multiple Sclerosis/drug therapy , Th1 Cells/drug effects , Blood Donors , Cell Differentiation/drug effects , Cells, Cultured , Dendritic Cells/immunology , Humans , Interleukin-12/biosynthesis , Multiple Sclerosis/immunology , Phenotype , Reference Values , T-Lymphocytes/immunology , Th1 Cells/immunologyABSTRACT
The pathogenesis of Kaposi's sarcoma (KS), a tumor of probable vascular origin, remains an enigma. It is still unclear whether KS is a true malignancy or whether it represents a reactive polyclonal process. Using both an immunohistochemical and an immunoblot approach, we found that cells derived from KS lesions express significant levels of Bcl-2, a protein known to prolong cellular viability and to antagonize apoptosis. Bcl-2 expression was found in AIDS-related KS-derived cells, as well as in cells derived from iatrogenic and sporadic KS, indicating that Bcl-2 upregulation may be important in the pathogenesis of KS regardless of its epidemiologic form. By contrast, fibroblasts and dermal microvascular endothelial, cells which are the probable vascular progenitors of KS cells, expressed low levels of Bcl-2. The expression of Bcl-2 in KS-derived cells was associated with a long-term survival in serum-deprived conditions, a situation that has been shown to induce apoptosis in various cell types. Incubation of fibroblasts or of dermal microvascular endothelial cells with KS cell-free supernatants did not enhance Bcl-2 expression, suggesting that Bcl-2 expression is not mediated by an agent released by KS cells. Analogously, KS supernatants failed to promote the viability of fibroblasts and of dermal microvascular endothelial cells cultured in serum-free conditions. Our findings suggest that the spindle cells derived from KS have a survival advantage and may adequately represent the tumor cells of KS.